Purchase Order 75F40119P10492
Award Date 8/13/19
Potential Completion Date 8/15/21
Potential Value $265K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $584,639 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Husson University, doing business as Nescom, for a research project titled "PREDICTING THE TRANSFER OF BREAST CANCER RESISTANT PROTEIN (BCRP) SUBSTRATES INTO HUMAN MILK USING IN VITRO TO IN VIVO EXTRAPOLATION (IVIVE)." The contract, which has a completion date of September 27, 2023, does not have a set-aside designation. Nescom, a private non-profit educational institution, is...
- This is a $301,019.50 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to The Research Foundation for the State University of New York (SUNY) for a project titled "Predicting the Transfer of Breast Cancer Resistant Protein (BCRP) Substrates into Human Milk Using In Vitro to In Vivo Extrapolation (IVIVE)". The contract has a period of performance through March 27, 2024 and does not have a set-aside designation. The Research Foundation for SUNY is a...
- This is a $3,526,785.00 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, doing business as the University of Michigan, for Prediction of In Vivo Performance Analysis Services. The contract has no set-aside designation. The University of Michigan is providing a range of research and development services under this contract, including developing high-performance computational models to simulate small intestine...
- This definitive contract awarded by the Food and Drug Administration (FDA) to Texas A&M University System Health Science Center Finance And Business Services Division is valued at $300,255 to develop an in-vitro quality metrics approach for bioequivalence demonstration between intramammary infusion products for animals. The work directly responds to the FDA's Fiscal Year 2022 Broad Agency Announcement for Advanced Research and Development of Regulatory Science, which sought proposals...
- This is a $130,080.00 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Innomics Inc., a for-profit small business contractor, for data-independent acquisition (DIA) quantitative proteomics protein profiling in mouse heart tissue and plasma. The award was made under a total small business set-aside and was based on a solicitation posted on April 15, 2020. Through past awards, Innomics Inc. has provided genomic sequencing,...
- This is a $117,933 firm fixed-price delivery order contract awarded to Trustees of Tufts College, doing business as Tufts University School of Medicine, a private non-profit educational institution. The contract was awarded by the Department of the Navy and is not set aside. It has an ultimate completion date of December 31, 2025. The contract appears to be part of a larger $146.3 million Indefinite Delivery Contract (IDC) held by Tufts University School of Medicine with the National Institute...
- This is a firm-fixed-price purchase order awarded to Vivitide LLC, doing business as New England Peptide, by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services. The $26,440.00 award is for the procurement of 2x NEP Monoclonal Antibody Packages. This purchase order was issued without a set-aside and has a completion date of March 21, 2021. The original solicitation was a special notice indicating NICHD's...
- This is a $150,120 firm fixed-price purchase order contract awarded by the U.S. Food and Drug Administration (FDA) to Kobenhavns Universitet, a university located in Copenhagen, Denmark. The contract is for the purpose of "Evaluating In Vitro Methods for Young Infants and Neonates." There is no set-aside designation, and the ultimate completion date is December 31, 2018. Kobenhavns Universitet is a non-profit organization that has received over $3 million in prior federal grant funding...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $110,914.00 firm-fixed-price purchase order to the University of California, San Diego (UCSD) to analyze 470 samples of human milk for human milk oligosaccharide (HMO) composition. This sole-source award was made under the statutory authority of 41 U.S.C. 1901(a)(1) since UCSD's Bode Lab is one of the few labs in the world capable of providing this...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to SB Drug Discovery LIMITED, a for-profit organization, to provide cultured cells stably expressing the human form of the NAV1.5 channel protein for use in in vitro electrophysiology and ion channel pharmacology projects. The contract has a ceiling value of $24,000.00 and was awarded on June 28, 2016 with a completion date of September 24, 2016. The award was not associated with any...